abstract |
The present invention relates to 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl) ethyl]-α,α-di New alpha and eta crystal forms of methyl-phenylacetic acid (bilastine). The present invention also relates to a method for its preparation, a pharmaceutical composition containing it, and its use in the treatment of histamine-mediated disease processes and allergic reactions. |